Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Louis

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Biotechniques|February 19, 1999
Epitope-based assay to determine the efficiency of cleavage by HIV-1 proteaseD Serio, I T Weber, R W Harrison, et al.
Revue De Pneumologie Clinique|January 1, 1987
[Cough induced by an inhibitor of the angiotensin-converting enzyme]J L Breton, P Pasquier, J C Dalphin, et al.
Proteins|May 8, 2001
Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexesB Mahalingam, J M Louis, J Hung, et al.
Advances in Pharmacology (San Diego, Calif.)|October 3, 2000
HIV-1 protease: maturation, enzyme specificity, and drug resistanceJ M Louis, I T Weber, J Tözsér, et al.
Biochemistry|September 12, 2001
Probing the structure and stability of a hybrid protein: the human-E. coli thioredoxin chimeraJ M Louis, R E Georgescu, M L Tasayco, et al.
Journal of Molecular Biology|September 21, 2001
Structural basis for SRY-dependent 46-X,Y sex reversal: modulation of DNA bending by a naturally occurring point mutationE C Murphy, V B Zhurkin, J M Louis, et al.
Structure (London, England : 1993)|October 6, 1999
Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for functionR Ishima, D I Freedberg, Y X Wang, et al.
European Journal of Biochemistry|September 22, 1999
Effect of substrate residues on the P2' preference of retroviral proteinasesP Boross, P Bagossi, T D Copeland, et al.
Biochemistry|March 28, 1998
Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 proteaseJ M Louis, F Dyda, N T Nashed, et al.
Biochemical and Biophysical Research Communications|October 16, 1989
Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activityJ M Louis, C A Smith, E M Wondrak, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Biotechniques|February 19, 1999
Epitope-based assay to determine the efficiency of cleavage by HIV-1 proteaseD Serio, I T Weber, R W Harrison, et al.
Revue De Pneumologie Clinique|January 1, 1987
[Cough induced by an inhibitor of the angiotensin-converting enzyme]J L Breton, P Pasquier, J C Dalphin, et al.
Proteins|May 8, 2001
Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexesB Mahalingam, J M Louis, J Hung, et al.
Advances in Pharmacology (San Diego, Calif.)|October 3, 2000
HIV-1 protease: maturation, enzyme specificity, and drug resistanceJ M Louis, I T Weber, J Tözsér, et al.
Biochemistry|September 12, 2001
Probing the structure and stability of a hybrid protein: the human-E. coli thioredoxin chimeraJ M Louis, R E Georgescu, M L Tasayco, et al.
Journal of Molecular Biology|September 21, 2001
Structural basis for SRY-dependent 46-X,Y sex reversal: modulation of DNA bending by a naturally occurring point mutationE C Murphy, V B Zhurkin, J M Louis, et al.
Structure (London, England : 1993)|October 6, 1999
Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for functionR Ishima, D I Freedberg, Y X Wang, et al.
European Journal of Biochemistry|September 22, 1999
Effect of substrate residues on the P2' preference of retroviral proteinasesP Boross, P Bagossi, T D Copeland, et al.
Biochemistry|March 28, 1998
Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 proteaseJ M Louis, F Dyda, N T Nashed, et al.
Biochemical and Biophysical Research Communications|October 16, 1989
Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activityJ M Louis, C A Smith, E M Wondrak, et al.
Pageof 7